In the early stages of the arrival and spread of COVID-19 in the United States, I wrote in this space about my belief that one of the best places a smart investor should focus their attention is on healthcare stocks, including companies in the pharmacy space. Vaccine commentary and speculation continues to be a daily […]
Read MoreBuy Price: $4.50 or better Sell Price: TradersPro Sell Signal Genprex, Inc. operates as a clinical-stage gene therapy company. The company engages in developing technologies for cancer patients based upon a proprietary technology platform. Its platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then […]
Read MorePlus, the FDA granted Yale University’s saliva-based coronavirus test emergency use authorization, Sanofi is buying Principia Biopharma, and Amazon is mulling an investment in Rackspace Technologies.
Read MoreThe market’s activity over the last couple of weeks, with the S&P 500 and NASDAQ pushing to highs above pre-pandemic levels, and the Dow within shouting distance of its own early 2020 highs, seems to be giving a lot of investors reason to believe broad conditions are better than they really are. While there certainly […]
Read MoreTrade Setup Buy Target: $46.42 Sell Target: $51.11 Seagate Technology plc provides data storage technology and solutions in Singapore, the United States, the Netherlands, and internationally. The company offers hard disk and solid state drives, including serial advanced technology attachment, serial attached SCSI, and non-volatile memory express products; solid state hybrid drives; and storage subsystems.
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreBuy Price: $2.25 or better Sell Price: TradersPro Sell Signal PAVmed Inc. operates as a medical device company in the United States. The company’s lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous […]
Read MorePlus, It just got even more unlikely Congress will come to agreement on the next coronavirus relief bill before September, Novavax reached a deal with the U.K. for 60 million doses of its coronavirus vaccine, and Simon Property Group is teaming up with Authentic Brands Group to take over Lucky Brand.
Read MoreWith so much in flux about the financial markets and the health of the global economy, it can be a challenge to know how to best position yourself as an investor. It doesn’t really help to know that there are tens of thousands of available stocks to choose from, each of which can be used […]
Read MoreHowever, the Minneapolis Fed president says one move could still pave the way to a stronger economic recovery.
Read MoreFive of the market’s biggest names could be in a bubble. Here’s what you need to know now.
Read MoreStocks could head higher in the near term. Here’s why.
Read MoreThese 2 hot IPO stocks could be gearing up for more gains.
Read MoreAnalysts are bullish on these 5 stocks post-earnings.
Read MoreTrade Setup Buy Target: $22.94 Sell Target: $26.07 Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is developing small molecule drug candidates primarily engineered to increase muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac […]
Read More